their glycemic status were consecutively included in this study. Out of 114 cancer patients 23 patients had oncologic emergencies. Different variables of these 23 cases of oncologic emergencies were analyzed with co-relation to diabetic status, such as age, gender, demography, co-morbid conditions, clinical features, type of malignancy and treatment outcome. With prior informed consent of the patients data was collected and statistical analysis was done using SPSS software. Level of significance was calculated by chi-square test wherever applicable. P-value < 0.5 was considered significant. Cases were followed up during their hospital stay and after discharge. 'Recovered' was defined as improvement and return to baseline of both clinical and biochemical parameters following supportive management. Cases were defined 'deteriorated' if the patients' condition declined from baseline clinical and biochemical status during management. Patients who failed to return to the baseline status were defined as 'no response'. Patients who expired during hospitalization or after discharge were also noted.
Results:
In this study, we encountered 23 cases of oncological emergencies of different types out of total 114 cancer patients. The common emergencies observed were marrow failure, neutropenic sepsis and hypercalcemia. Other oncologic emergencies (Table-I ) included increased intracranial pressure (ICP) with or without seizure, superior vena caval syndrome (SVCO), syndrome of inappropriate anti diuretic hormone secretion (SIADH), tumor lysis syndrome (TLS) and spinal cord compression.
Among these 23 cases of oncologic emergencies, two-third of the patients were male (69.57%) and 7 patients were female (30.43%, Table-I). Table II shows distribution according to age and area of residence. Age in most of the cases was above 60 years (43.5%). The glycemic status of these patients were noted (Table III) . Two-third of the patients were diabetic (17, 73.91%) while the remainder were non-diabetic (6, 26.09%). Data were analyzed relating co-morbidities to diabetic status (Table IV) . It was observed that there were 10 cases (43.48%) with 'more than one' co-morbid conditions and all of them belonged to the diabetic group. Those who had no co-morbidities (6, 26.09%) were all non-diabetic. Rest of the patients had hypertension (5, 21.74%) and ischemic heart disease (2, 8.7%), who all belonged to the diabetic group. Among the 23 cases only 3 (13.04%) patients recovered from oncologic emergency to baseline status. The condition of 4 patients (17.39%) remained static without further improvement and 4 patients (17.39%) deteriorated. It is worth mentioning that in the diabetic group recovery rate was poor and non-responder /deterioration /death / lost from follow up cases were comparatively more. Unfortunately there were 3 cases of death and 9 patients denied further treatment or were lost from follow up (Table VII) . When patients with diabetes are affected with cancer the situation gets complicated. They need special amenities to deal with complications related to both diabetes and malignancy. In order to share our experience in the field of oncology we conducted a small sample based study of 23 oncological emergencies occurring among 114 cases of malignancies in BIRDEM General Hospital.
Oncologic emergencies can occur at any time during the course of malignancy, from presenting symptom to the end stage of the disease. 1 In addition, the emergency may also arise from the side-effect of anticancer treatment administered to the patient. 3 Efficient diagnosis and proper management of life-threatening complications may facilitate either definitive treatment of the underlying malignancy or palliation. 4 There are few studies in our country about cancer patients but there is no study showing its relation to glycemic status and documentation of oncologic emergencies.
In this study 114 cases of cancer patients were encountered among which 23 cases of oncologic emergencies were documented. As this hospital mainly serves diabetic patients, two-third of the cases were found to be diabetic (17, 73.91%). Eight types of oncologic emergencies were encountered during this period occurring in 11 different categories of malignancies. These emergencies occurred in different phases of the malignancies, even after/during treatment.
Among the emergencies, marrow failure, neutropenic sepsis and hypercalcemia together were 15 cases, reflecting 65.22% of the total oncological emergencies found. It was also observed that marrow failure, neutropenic sepsis, hypercalcemia and SIADH were more common in the diabetic group. This correlates the common oncological emergencies mentioned in textbook of oncology, 'Handbook of Cancer Chemotherapy' (Lippincott Williams & Wilkins). 5 Age group distribution showed that 82.61% (19 cases) were in 41-60 years and 60 years above groups. This nearly correlates to the statistics of Bangladesh Cancer Registry Report. 6 The mean age of the diabetic group was 59.06 years and that of the non-diabetic group was 35.67 years with a total mean age 52.96 years.
Patients coming from urban and sub-urban background (20 cases) reflected 87% of the study sample. This indirectly reflects the economic status of the admitted patient in BIRDEM and their ability to attain care at a tertiary care hospital level. In this study it is also noteworthy that all diabetic patients had co-morbidities whether single or multiple. On the other hand, none of the non-diabetic patients had any co-morbid conditions (p = 0.002).
Clinical features during oncologic emergencies 6 cases (26.09%) had 'more than one' features of whom 5 were diabetic (5, 21.74%). Other clinical features were according to the different diagnoses of malignancies. The common malignancies in this study were leukaemia, carcinoma lung, pancreatic carcinoma, multiple metastasis followed by carcinoma uterus/cervix, lymphoma and multiple myeloma. In Bangladesh, according to a large study on cancer patients conducted in National Institute of Cancer Research and Hospital of Bangladesh, the common cancers in adult males included cancers of lung, lymphatics, larynx, oral cavity and skin, while in adult females breast, cervix, lung, oral cavity, lymphatics and ovarian cancer were common. 7 The outcome among the 23 cases were variable. Recovery rate from oncologic emergencies was low (13.04%) in the diabetic group while a higher rate was observed in the non-diabetic group. Death, deterioration and non-responders were also more in the diabetic group. Similar observations were mentioned in a large retrospective cohort study of 112,408 patients which was carried out in more than 350 primary care practices in the United Kingdom. The study also stated that solid-tumor cancer was associated with shorter survival in people with type 2 diabetes. 8 In our study, the number of lost from follow up cases were considerable (9, 39.13%) which was mostly due to the financial compromise to continue treatment including intensive care support and reluctance to continue further hospital stay owing to lack of optimistic improvement.
Conclusion:
Our study suggests that patients with malignancy and diabetes mellitus are more prone to develop oncological emergencies and are also associated with co-morbidities. Our hospital has abundant patients with diabetes mellitus and as such is an ideal place for such a study. Our study assessing the significance of glycemic status in oncological emergencies is the first reported study in Bangladesh. This is a small scale preliminary study and further study involving multi-centre with larger population is warranted.
